Transition of Care & Self-Management
The transition from pediatric to adult epilepsy care is a critical and often poorly managed period that places patients at increased risk for seizure exacerbation, medication nonadherence, loss to follow-up, and psychosocial deterioration. Adolescents and young adults with epilepsy face a convergence of biological, psychological, and social challenges — including changes in seizure patterns, evolving developmental needs, assumption of self-care responsibilities, and navigation of complex health care systems — that demand structured transition planning. Beyond the pediatric-to-adult handoff, effective epilepsy self-management throughout the lifespan requires education, digital health tools, evidence-based self-management programs, and attention to the health disparities that disproportionately affect underserved populations. Quality measures developed by the AAN and learning health systems provide a framework for standardizing and improving the continuum of epilepsy care.
Bottom Line
- Transition planning: Should begin at age 12–14 and complete by age 18–21; the AAN child neurology quality measure set includes a transition plan measure as a core quality indicator
- High-risk period: The transition period (ages 16–25) is associated with the highest rates of medication nonadherence, loss to follow-up, emergency department utilization, and SUDEP risk in the lifespan
- Self-management programs: Evidence-based programs (HOBSCOTCH, WebEase, SMART, Project UPLIFT) improve quality of life, medication adherence, and cognitive outcomes in adults with epilepsy
- Digital health tools: Seizure tracking apps, electronic pill reminders, and telehealth platforms demonstrate feasibility and may improve seizure documentation and medication adherence
- Health disparities: Black and Hispanic patients are less likely to see a neurologist, receive epilepsy surgery, or access specialized epilepsy centers; median time from first seizure to diagnosis is 19 months in Medicaid populations, with significant racial and geographic variation
- Quality measures: The AAN has developed and iteratively updated epilepsy quality measure sets (2010, 2015, 2017, 2021) to standardize care; the Epilepsy Learning Healthcare System provides a collaborative framework for measuring and improving care gaps
- Telemedicine: Telehealth visits are better attended than in-person visits for epilepsy care, though racial and socioeconomic disparities in no-show rates persist even in virtual settings
Pediatric-to-Adult Transition
The Challenge
Transitioning from pediatric to adult epilepsy care involves far more than a simple transfer of medical records. The pediatric model is typically family-centered, with parents managing appointments, medications, and communication with providers. The adult model shifts responsibility to the patient, who must independently navigate insurance, scheduling, medication refills, and self-advocacy. This shift occurs during adolescence and young adulthood — a period characterized by neurobiological immaturity in executive function, risk-taking behavior, peer influence, and identity formation — creating a “perfect storm” for care disruption.
Studies consistently demonstrate adverse outcomes during this period. Young adults with epilepsy have the highest rates of nonadherence to antiseizure medications (up to 40–60%), loss to neurologic follow-up (30–50%), and emergency department visits and hospitalizations for seizure-related events. Insurance transitions from pediatric to adult coverage are an independent risk factor for healthcare disruption, particularly in families moving from Medicaid to private insurance or losing coverage entirely.
Structured Transition Planning
| Phase | Age Range | Key Activities |
|---|---|---|
| Preparation | 12–14 years | Introduce concept of transition; begin seizure education directed at the patient (not just parents); assess self-management readiness; develop medical knowledge portfolio |
| Skill Building | 14–16 years | Patient learns to describe seizure types, name medications and dosages; begins managing medication reminders; attends part of clinic visit independently; introduces driving and safety discussions |
| Pre-Transfer | 16–18 years | Patient manages medication refills; understands insurance basics; can contact clinic and pharmacy independently; has written emergency seizure plan; identifies adult neurologist/epileptologist |
| Transfer | 18–21 years | Formal handoff with medical summary and direct communication between pediatric and adult providers; warm introduction to new care team; first adult clinic visit scheduled before last pediatric visit |
| Integration | 21–25 years | Follow-up to ensure establishment with adult provider; continued assessment of self-management competency; address emerging psychosocial needs (employment, relationships, family planning) |
AAN Transition Quality Measure
- The 2016 Child Neurology Quality Measurement Set includes a measure for “Transition From Pediatric Neurology to Adult Neurology”: the percentage of patients who had a neurologic transition plan of care documented
- Essential elements of a transition plan include: written medical summary; medication list with indication, dose, and administration; seizure types and frequency; prior treatments and their outcomes; current EEG and neuroimaging results; comorbidities (psychiatric, cognitive, behavioral); emergency seizure plan; and identification of receiving adult provider
- The Got Transition national resource center provides toolkits and customizable transition checklists for chronic conditions including epilepsy
Barriers to Successful Transition
- Provider factors: Shortage of adult epileptologists; discomfort of adult neurologists managing conditions diagnosed in childhood (e.g., Dravet syndrome, tuberous sclerosis complex); lack of structured transition programs in most neurology practices
- Patient factors: Limited health literacy; executive function deficits (common in epilepsy); reluctance to leave familiar pediatric providers; denial of diagnosis during adolescence
- System factors: Insurance transitions at age 18–26; lack of standardized transition protocols; poor communication between pediatric and adult providers; geographic distance from specialized epilepsy centers
- Family factors: Parental anxiety about releasing control; overprotectiveness that inhibits self-management skill development; caregiver burnout
Self-Management in Epilepsy
Core Self-Management Skills
Epilepsy self-management encompasses the knowledge, skills, and behaviors that enable people with epilepsy to manage their condition effectively in daily life. Core domains include medication adherence, seizure recognition and tracking, trigger identification and avoidance, safety awareness, mental health monitoring, and navigation of health care systems.
| Self-Management Domain | Key Skills | Tools / Resources |
|---|---|---|
| Medication adherence | Understanding medication purpose, dosing, and side effects; managing refills; recognizing nonadherence | Pill organizers, electronic reminders, pharmacy auto-refill, adherence apps (Medisafe, Epsy) |
| Seizure tracking | Recording seizure type, frequency, duration, and triggers; maintaining seizure diary | Seizure diary apps (Seizure Tracker, EpiDiary, My Seizure Diary); wearable devices |
| Trigger management | Identifying and avoiding personal seizure triggers (sleep deprivation, alcohol, stress, missed medications) | Sleep hygiene education, stress management programs, counseling |
| Safety awareness | Seizure precautions (shower vs. bath, no unsupervised swimming, driving restrictions, workplace safety) | Epilepsy Foundation safety checklists, medical alert identification |
| Mental health | Recognizing symptoms of depression and anxiety; seeking help; stress management | PHQ-9, GAD-7, NDDI-E screening; Project UPLIFT; therapy referral |
| Healthcare navigation | Scheduling appointments, managing insurance, communicating with providers, understanding EHR portals | Patient advocacy organizations, social workers, transition programs |
Evidence-Based Self-Management Programs
The CDC’s Managing Epilepsy Well (MEW) Network has supported the development and evaluation of several evidence-based self-management programs for people with epilepsy. These programs target different populations and outcomes but share a common focus on empowering patients through education, skill building, and behavioral strategies.
| Program | Format | Target Population | Outcomes | Evidence |
|---|---|---|---|---|
| HOBSCOTCH (Home-Based Self-Management and Cognitive Training Changes Lives) | 8 weekly one-on-one telehealth sessions with a certified cognitive coach | Adults with epilepsy and subjective cognitive dysfunction | Improved quality of life, subjective cognition, and self-efficacy | RCT (2016); multicenter pragmatic trial (n=205, 2022); significant improvements in QOLIE and cognitive outcomes |
| WebEase (Web Epilepsy Awareness, Support, and Education) | 3 interactive online modules (medication, stress, sleep) | Adults with epilepsy | Improved medication adherence, sleep quality, and self-management self-efficacy | Pilot RCT (Emory University); feasibility demonstrated; improvement in medication self-efficacy and stress management scores |
| SMART (Self-Management for People with Epilepsy and a History of Negative Health Events) | Group-based program targeting rural and underserved populations | Adults with epilepsy in rural areas with history of adverse health events | Targets medication adherence, safety, mental health, and emergency preparedness | RCT protocol published (Ghearing et al., 2021); ongoing multicenter evaluation |
| Project UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) | 8-week internet/telephone-based program using CBT and mindfulness | Adults with epilepsy and depression | Significant reduction in depression severity; improved knowledge of depression and seizure triggers | RCT (Thompson et al., 2010); replicated; depression improvements maintained at 6-month follow-up |
| PACES in Epilepsy (Program for Active Consumer Engagement in Self-management) | 6-session group program | Adults with epilepsy | Improved self-management and epilepsy knowledge | Pilot study; feasibility and preliminary efficacy demonstrated |
Digital Health and Telemedicine
Seizure Tracking Applications
Multiple smartphone applications are available for seizure tracking, including Seizure Tracker, EpiDiary, My Seizure Diary (Epilepsy Foundation), and Epsy. These apps allow patients to record seizure events, medication doses, triggers, and mood, generating reports that can be shared with providers. The 2022 AAN seizure frequency quality measures emphasize the importance of systematic, standardized seizure documentation at each clinical encounter — a process that seizure tracking apps can facilitate.
Telemedicine in Epilepsy Care
The rapid expansion of telemedicine during the COVID-19 pandemic demonstrated the feasibility of delivering high-quality epilepsy care remotely. Studies from level 4 epilepsy centers showed that telemedicine visits achieved high completion rates for standardized seizure-related documentation and quality measures, comparable to in-person visits. Virtual visits are better attended than in-person visits across epilepsy populations.
Telemedicine: Benefits and Limitations in Epilepsy
- Benefits: Improved access for rural and underserved populations; reduced travel burden (level 4 epilepsy centers are concentrated in urban areas, with 8 states having no centers); higher visit attendance rates; reduced cost; feasibility for routine follow-up, medication management, and counseling
- Limitations: Cannot perform neurologic examination, EEG, or neuroimaging; limited ability to assess subtle cognitive changes; technology barriers (internet access, device availability, digital literacy) disproportionately affect low-income and elderly populations
- Persistent disparities: Even with telemedicine, patients with Medicare/Medicaid, lower income, and minority race have higher no-show rates (Yardi et al., 2023), suggesting that technology alone does not eliminate health care access disparities
- NAEC recommendation: The 2024 NAEC guidelines for specialized epilepsy centers recognize telehealth as an important tool for increasing access to specialized care, particularly for presurgical evaluation counseling and post-surgical follow-up
Health Disparities in Epilepsy
Racial and Ethnic Disparities
Health disparities in epilepsy care are well documented and persistent, affecting diagnosis, treatment, and outcomes. A systematic body of evidence demonstrates that racial and ethnic minority populations experience delayed diagnosis, reduced access to specialist and surgical care, and worse seizure outcomes compared with White populations.
| Disparity | Finding | Source |
|---|---|---|
| Time to diagnosis | Median 19 months from first seizure to diagnosis in Medicaid populations; American Indian, Alaskan Native, Asian, and Pacific Islander patients had longest time to diagnosis | Bensken et al., 2020 |
| Neurologist access | Black and Hispanic patients 30–40% less likely to see an outpatient neurologist than White patients | Saadi et al., 2017 |
| Epilepsy surgery | Black and Hispanic children less likely to undergo surgery regardless of insurance type; racial differences in time to surgery confirmed in meta-analysis | Howard et al., 2023; Kandregula et al., 2022 |
| Epilepsy center distribution | 8 states have no level 4 epilepsy centers; centers concentrated in urban, higher-income areas | Louis et al., 2021 |
| Quality of care experiences | All racial and ethnic minority groups in Medicaid reported worse experiences across 4 care measures vs. White enrollees | Nguyen et al., 2022 |
| Insurance transitions | Insurance transitions in children with drug-resistant epilepsy increase hospitalizations and ED visits | Pan et al., 2018 |
| Research participation | Significant decrease in Black participants in ASM trials from 20% (2007–2013) to 8% (2014–2019) | Kong et al., 2021 |
Socioeconomic and Geographic Disparities
Lower socioeconomic status is associated with higher epilepsy prevalence, reduced access to neurological care, greater medication nonadherence, worse seizure outcomes, and lower quality of life. Children from disadvantaged neighborhoods have reduced quality of life even after adjusting for epilepsy severity. Geographic distance from epilepsy centers — which are concentrated in metropolitan academic hospitals — creates significant access barriers for rural populations. The confluence of racial, economic, and geographic disadvantage amplifies health care delays and disparities.
Addressing Health Disparities: Key Initiatives
- CDC Managing Epilepsy Well Network: Funds research on epilepsy self-management interventions specifically designed for underserved populations, including rural communities and racial minorities
- Healthy People 2030 / Vision 20-30: Emphasizes reducing epilepsy care disparities and expanding self-management access as national health objectives
- Intersectoral Global Action Plan on Epilepsy (WHO): Approved by the World Health Assembly to close education, research, clinical, and social gaps in epilepsy care globally
- Telemedicine expansion: Has the potential to reduce geographic barriers, but must be paired with strategies to address digital divide (device access, broadband availability, digital literacy)
- Culturally concordant care: Linguistic and cultural concordance between patients and providers improves trust, communication, and health care utilization
- Diverse research representation: The National Institutes of Health and funding agencies have issued mandates to improve diversity in research participants, investigators, and grant funding
Epilepsy Centers and Referral Patterns
The National Association of Epilepsy Centers (NAEC) accredits level 3 and level 4 epilepsy centers in the United States. Level 4 centers provide the highest level of medical and nonmedical treatment, including presurgical evaluation, invasive monitoring, and resective and ablative surgery. Despite strong evidence that epilepsy surgery is effective and underutilized, referral patterns have not significantly improved since the publication of the AAN practice parameter in 2003 recommending referral for surgical evaluation after failure of two appropriate ASMs. An ILAE Surgical Therapies Commission Delphi consensus (2022) recommended referral of all patients with drug-resistant epilepsy to specialized centers regardless of seizure type, duration, or sociodemographic factors.
Quality Measures in Epilepsy Care
AAN Epilepsy Quality Measurement Sets
The AAN has developed and iteratively updated epilepsy quality measures since 2010. These measures operationalize clinical practice guidelines into quantifiable metrics for assessing care quality at the provider, practice, and population levels.
| Measure Domain | Current Status (2021/2017) | Description |
|---|---|---|
| Seizure type, frequency, and time since last seizure | Active (2021 update) | Documentation of seizure type, frequency category, and time since last seizure using standardized terminology at each encounter |
| Seizure freedom | Active (2021 update) | Outcome measure: proportion of patients who are seizure-free |
| Tonic-clonic seizure reduction | Active (2021 update) | Outcome measure: proportion of patients with reduction in GTCS frequency |
| Comprehensive epilepsy center referral | Active (2017) | Process measure: referral to or discussion of comprehensive epilepsy center for patients with intractable epilepsy |
| Counseling for women of childbearing potential | Active (2017) | Process measure: annual counseling on folic acid, drug interactions, teratogenesis |
| Depression and anxiety screening | Active (2017) | Process measure: screening at each encounter |
| Quality of life assessment / outcome | Active (2017) | Process and outcome measure: assessment using validated PROM (QOLIE-10, PROMIS-10) |
Patient Education Resources
Key Patient Organizations and Resources
- Epilepsy Foundation (epilepsy.com): Largest US epilepsy organization; provides education, advocacy, support services, seizure first aid training, driving laws database, and clinical trial matching
- CURE Epilepsy (cureepilepsy.org): Funds research; provides patient/family education; SUDEP awareness and prevention programs
- Epilepsy Alliance America (epilepsyallianceamerica.org): Network of local epilepsy organizations; hosts HOBSCOTCH program delivery; community support services
- Danny Did Foundation (dannydid.org): Focused on SUDEP awareness; funds seizure detection device grants for families
- Managing Epilepsy Well Network (managingepilepsywell.org): CDC-funded network developing and disseminating evidence-based self-management programs
- Got Transition (gottransition.org): National resource center for health care transition; provides toolkits and readiness assessments for chronic conditions including epilepsy
References
- Patel AD, Berg AT, Billinghurst L, et al. Quality improvement in neurology: child neurology quality measure set: executive summary. Neurology. 2018;90(2):67–73.
- Munger Clary H, Josephson SA, Franklin G, et al. Seizure frequency process and outcome quality measures: quality improvement in neurology. Neurology. 2022;98(14):583–590.
- Patel AD, Baca C, Franklin G, et al. Quality improvement in neurology: epilepsy quality measurement set 2017 update. Neurology. 2018;91(18):829–836.
- Baca CM, Benish S, Videnovic A, et al. Axon Registry data validation. Neurology. 2019;92(18):847–858.
- Donahue MA, Herman ST, Dass D, et al. Establishing a learning healthcare system to improve health outcomes for people with epilepsy. Epilepsy Behav. 2021;117:107805.
- Bensken WP, Navale SM, Andrew AS, et al. Delays and disparities in diagnosis for adults with epilepsy: findings from U.S. Medicaid data. Epilepsy Res. 2020;166:106406.
- Saadi A, Himmelstein DU, Woolhandler S, Mejia NI. Racial disparities in neurologic health care access and utilization in the United States. Neurology. 2017;88(24):2268–2275.
- Howard SD, Campbell PA, Montgomery CT, et al. Effect of race and insurance type on access to, and outcomes of, epilepsy surgery: a literature review. World Neurosurg. 2023;178:202–212.
- Louis S, Rabah N, Rammo R, Bingaman W, Jehi L. Disparities in the nationwide distribution of epilepsy centers. Epilepsy Behav. 2021;125:108409.
- Yardi R, McLouth CJ, Mathias S, Jehi L. Telemedicine as a path to bridging inequities in patients with epilepsy. Epilepsia. 2023;64(12):3238–3245.
- Ghearing GR, Briggs F, Cassidy K, et al. A randomized controlled trial of self-management for people with epilepsy and a history of negative health events (SMART). Trials. 2021;22(1):821.
- Fraser RT, Johnson EK, Miller JW, et al. Managing epilepsy well: self-management needs assessment. Epilepsy Behav. 2011;20(2):291–298.
- Thompson NJ, Walker ER, Obolensky N, et al. Distance delivery of mindfulness-based cognitive therapy for depression: Project UPLIFT. Epilepsy Behav. 2010;19(3):247–254.
- Pan IW, Lam S, Clarke DF, Shih YCT. Insurance transitions and healthcare utilization for children with refractory epilepsy. Epilepsy Behav. 2018;89:48–54.
- Nguyen KH, Wilson IB, Wallack AR, Trivedi AN. Racial and ethnic disparities in patient experience of care among nonelderly Medicaid managed care enrollees. Health Aff. 2022;41(2):256–264.
- Kong WY, Saber H, Marawar R, Basha MM. Racial and ethnic trends in antiseizure medications trial enrolment: a systematic review. Epilepsy Res. 2021;173:106613.
- Moura LMVR, Donahue MA, Smith JR, et al. Telemedicine can support measurable and high-quality epilepsy care during the COVID-19 pandemic. Am J Med Qual. 2021;36(1):5–16.
- Lado FA, Ahrens SM, Riker E, et al. Guidelines for specialized epilepsy centers: executive summary. Neurology. 2024;102(4):e208087.
- Jehi L, Jette N, Kwon CS, et al. Timing of referral to evaluate for epilepsy surgery: expert consensus recommendations. Epilepsia. 2022;63(10):2491–2506.
- Clarke DF. Diversity and underserved patient populations in epilepsy. Continuum (Minneap Minn). 2025;31(1):247–264.
- Baca CM. Implementing guidelines and measures in epilepsy care. Continuum (Minneap Minn). 2025;31(1):265–285.